Jinhe Biotechnology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001HK7
CNY
5.95
0.54 (9.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
741.88
841.90
645.94
765.11
619.26
713.35
591.53
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
741.88
841.90
645.94
765.11
619.26
713.35
591.53
Raw Material Cost
477.57
581.20
462.53
533.20
426.26
491.67
416.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
20.29
24.00
20.94
22.93
22.08
22.91
19.40
Selling and Distribution Expenses
138.63
137.14
124.36
95.16
100.22
146.60
104.24
Other Expenses
-0.08
0.06
1.18
-0.44
-0.48
0.97
-0.47
Total Expenditure (Excl Depreciation)
635.64
742.89
619.63
646.90
543.74
670.85
535.45
Operating Profit (PBDIT) excl Other Income
106.19999999999999
99
26.299999999999997
118.2
75.5
42.5
56.1
Other Income
-2.66
0.19
4.52
9.22
5.62
24.20
-2.04
Operating Profit (PBDIT)
97.42
-35.24
84.21
183.01
141.76
48.20
95.18
Interest
20.29
24.00
20.94
22.93
22.08
22.91
19.40
Exceptional Items
-0.16
0.02
0.25
-0.01
-0.03
-0.03
0.04
Gross Profit (PBDT)
264.31
260.69
183.41
231.92
193.00
221.69
175.06
Depreciation
0.00
62.39
62.39
60.06
60.06
51.68
51.68
Profit Before Tax
76.97
-121.60
1.12
100.02
59.60
-26.43
24.13
Tax
13.63
24.16
4.29
13.86
7.82
2.32
1.66
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
62.30
-111.51
1.15
86.80
51.12
-13.56
22.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
62.30
-111.51
1.15
86.80
51.12
-13.56
22.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.04
-34.25
-4.32
-0.63
0.67
-15.18
-0.27
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
63.34
-145.77
-3.17
86.17
51.78
-28.74
22.47
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,285.07
2,228.40
2,349.51
2,320.16
2,303.06
2,246.61
2,241.36
Earnings per share (EPS)
0.08
-0.15
0.0
0.12
0.07
-0.02
0.03
Diluted Earnings per share
0.08
-0.15
0.0
0.12
0.07
-0.02
0.03
Operating Profit Margin (Excl OI)
13.49%
-11.62%
2.68%
14.87%
12.29%
-3.88%
7.7%
Gross Profit Margin
10.38%
-7.03%
9.83%
20.92%
19.32%
3.54%
12.82%
PAT Margin
8.4%
-13.25%
0.18%
11.35%
8.25%
-1.9%
3.84%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -11.88% vs 30.35% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 143.42% vs -4,456.25% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 382.77% vs -144.42% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -15.42% vs 14.83% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Jinhe Biotechnology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
741.88
0
741.88
Other Operating Income
0.00
0.00
0.00
Total Operating income
741.88
0
741.88
Raw Material Cost
477.57
0
477.57
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
20.29
0
20.29
Selling and Distribution Expenses
138.63
0
138.63
Other Expenses
-0.08
0.00
-0.08
Total Expenditure (Excl Depreciation)
635.64
0
635.64
Operating Profit (PBDIT) excl Other Income
106.24
0.00
106.24
Other Income
-2.66
0
-2.66
Operating Profit (PBDIT)
97.42
0
97.42
Interest
20.29
0
20.29
Exceptional Items
-0.16
0
-0.16
Gross Profit (PBDT)
264.31
0
264.31
Depreciation
0.00
0
0.00
Profit Before Tax
76.97
0
76.97
Tax
13.63
0
13.63
Provisions and contingencies
0
0
0.00
Profit After Tax
62.30
0
62.30
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
62.30
0
62.30
Share in Profit of Associates
0
0
0.00
Minority Interest
1.04
0
1.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
63.34
0
63.34
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,285.07
0
2,285.07
Earnings per share (EPS)
0.08
0
0.08
Diluted Earnings per share
0.08
0
0.08
Operating Profit Margin (Excl OI)
13.49%
0%
0.00
13.49%
Gross Profit Margin
10.38%
0%
0.00
10.38%
PAT Margin
8.40%
0%
0.00
8.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 74.19 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -11.88% vs 30.35% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 19.80% vs 19.21% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.33 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 143.42% vs -4,456.25% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 22.20% vs 8.82% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.01 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 382.77% vs -144.42% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -26.45% vs 26.49% in Mar 2025

Quarterly - Interest
Interest 2.03 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -15.42% vs 14.83% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -8.14% vs 17.55% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.49%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025